Clinical trial
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic…
NCT00004218 · Leukemia Research Fund, Other · Completed
Key facts
| NCT number | NCT00004218 |
|---|---|
| Title | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia |
| Official title | Chronic Lymphocytic Leukemia Trial 4: A Randomized Comparison of Chlorambucil, Fludarabine and Fludarabine Plus Cyclophosphamide |
| Lead sponsor | Leukemia Research Fund, Other |
| Collaborators | Medical Research Council |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | chlorambucil, cyclophosphamide, doxorubicin hydrochloride, fludarabine phosphate, prednisolone, vincristine sulfate |
| Start date | Oct 1, 1999 |
| Completion | Jul 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | Argentina, Croatia, Greece, Ireland, Italy, New Zealand, Russia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: